Bullish
Citizens Raises Sutro Biopharma Price Target to 41 Dollars
Citizens has increased its price target for Sutro Biopharma (NASDAQ:STRO) from $35 to $41, maintaining an Outperform rating, due to strong preclinical...
STRO
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest STRO News
Bullish
Research STRO on:
Ad Space